QZKClass 3
Endovascular System For Treatment Of Thoracoabdominal And Pararenal Aortic Lesions
FDA adverse event reports and recall history for endovascular system for treatment of thoracoabdominal and pararenal aortic lesions (product code QZK), from the public MAUDE corpus and the live FDA recall database.
- Total reports
- 162
- Deaths
- 22
- Injuries
- 122
- Malfunctions
- 18
Reports per year
1624
6925
7726
Source: FDA adverse event reports by year received, 2024–2026. Reporting paused twice in 2026 during FDA reporting-system changes and has since resumed.
Recent recalls
No recalls listed in the FDA device recall database for this entry.
Monitor endovascular system for treatment of thoracoabdominal and pararenal aortic lesions automatically
DeviceWatch watches FDA adverse events and recalls for the products you care about, summarizes clinical narratives with AI and alerts you when a safety signal emerges.